This study investigates the development of intra-abdominal hypertension and compartment syndrome in patients undergoing elective pancreatic procedures. Main objective is to determine the proportion of patients after pancreatic operation who develop elevated intra-abdominal pressure and assess its association with postoperative complication rates. Another goal of the study is to compare open versus robotic pancreatic procedures regarding the occurrence of intra-abdominal hypertension and abdominal compartment syndrome.
HYPA study is designed as a prospective observational study. The primary objective of this study is to assess the risk and prevalence of intra-abdominal hypertension and abdominal compartment syndrome following pancreatic procedures. The secondary objective aims to explore potential correlations between intra-abdominal hypertension and the development of postoperative complications, such as anastomotic dehiscence, postoperative pancreatic fistulas, prolonged postoperative ileus, or delayed gastric emptying. The third objective is to compare the incidence of intra-abdominal hypertension in patients undergoing robotic versus open pancreatic procedures
Study Type
OBSERVATIONAL
Enrollment
150
Department of Surgery 2nd Faculty of Medicine, Charles University and Military University Hospital Prague
Prague, Prague 6, Czechia
Prevalence of Intra-abdominal hypertension and abdominal compartment syndrome
Prevalence of intra-abdominal hypertension and abdominal compartment syndrome in patients following pancreatic procedures.
Time frame: From the admission to the intensive care unit until the postoperative day 7 or until discharge from the ICU
Correlation between intra-abdominal hypertension and the development of postoperative complications.
The secondary objective aims to explore potential correlations between intra-abdominal hypertension and the development of postoperative complications, such as anastomotic dehiscence, postoperative pancreatic fistulas, prolonged postoperative ileus, or delayed gastric emptying.
Time frame: From the enrollment to the 90 days follow up period.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.